Gloucester Pharmaceuticals
Biopharmaceutical company that developed ISTODAX (romidepsin), an HDAC inhibitor for T-cell lymphoma. Acquired by Celgene in 2009.
Location
Cambridge, Massachusetts, USA
Founded
2003
Investors
1
Categories
biotech, oncology, epigenetics, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |